Booster Shots Getting Regulatory Approval As Data Shows Protection Lasts Up To 8 Months
A study shows that protective antibodies are present for up to 8 months. This is reflected in Israel, the first country to mass vaccinate its population. Reports out of Israel show that immunity is starting to wane and that booster shots are needed for further protection.
Hospitals Pay Bills Through Predatory Tactics Against Their Patients
America’s top 10 hospitals use “predatory billing” against patients to make their money. Until the blame is shifted from pharma companies to hospitals, patients will continue to suffer with marked-up pricing and high deductibles.
Vaccines Protect Against Indian Variant, Next Time We May Not Be As Lucky
Research shows a Covid variant identified in India to be less susceptible to antibody neutralization. Though data proves mRNA-based vaccines retain protective immunity over this variant, booster vaccines will likely be needed to keep up with emerging variants over time.
Politicians Have It Wrong: Drug Pricing Is Not The Problem
US politicians claim that drug pricing is to blame for high healthcare costs when in reality hospital expenditures are the biggerdrivers.
AstraZeneca COVID Vaccine Still Works, Even Though Their Marketing Tactics Don’t
Pharmaceutical company, AstraZeneca is being questioned about the safety and efficacy of their vaccine. However, data shows that it still has an efficacy of 76% for those with symptomatic COVID.
New Weight Loss Paradigm: Diabetic Drugs Showing Promise As Treatments
Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable side effects. These interventions are forecasting a shift in weight loss medication.
Moderna CEO Is Right, COVID Is Here To Stay
A deeper dive into the research published by pharma companies shows that efficacy of COVID vaccines may not be as high as once thought.
The Government Measures Most Effective At Limiting COVID Spead
This study analyzes the effectiveness of certain lockdown interventions on preventing the transmission of COVID. The implementation of certain measures over others can lower the transmission rate. Read about which ones performed best.
Debunked: Economic Implications of COVID Lockdowns
An analyses of how the economies and health outcomes of several countries were impacted by lockdown policies.
Telemedicine in Amazon’s Future After Entry In Prescription Delivery Service?
Amazon launched their online pharmacy delivery service which provides patients with their prescriptions at their doorstep within days. Does this move foreshadow their next step: to provide virtual care services for patients to speak with doctors online?
Aging Expert Dr. Alex Zhavoronkov Discusses Future of The Longevity Space
Read what an expert in the field of aging has to say about recent developments and future endeavours.
Moderna and Pfizer Challenge the Status Quo with New mRNA Vaccine Approach
Both companies have shown efficacy rates in the range of 95% however, their phase 3 trials are still ongoing with more data to come out soon.
Drug Approval of Aducanumab for Alzheimer’s Gets Shut Down by AdCom, Now the FDA Must Decide
A panel of experts voted against aducanumab for the treatment of Alzheimer’s disease, claiming the data does not show sufficient efficacy. Now the final decision lies in the hands of the FDA.
Technologies Making 100th Birthday A Normality
Read about the latest in aging news and the technologies being developed that could make celebrating your 100th birthday possible.
Get The Newsletter
⇒ Analysis of the latest life science news
⇒ Coverage of pharma, healthcare and biotech
⇒ Interviews and insights with industry insiders